We are a venture company that continues to take on new challenges, driven by the belief that business has the power to solve social issues.
In the fields of medicine and health, technological innovation is not a goal in itself. What truly matters is the value that such technology can bring to society. Our work always begins with a single question, Whose future will this technology change?
By combining the world’s only robotic hair-cutting technology with the groundbreaking hair exposome analysis developed by Linus Biotechnology in the United States, we have created the world’s first diagnostic support service derived from hair. Following our launch in the U.S., we have now begun offering this service in Japan, presenting society with a new option in preventive healthcare.
A single strand of hair contains a chronological record of a person’s lived experience. By scientifically visualizing this information, we aim to enable the early detection and early intervention of conditions such as autism. Early recognition and early support can have profound impact—not only for the individual, but also for families, educational settings, and society as a whole.
Yet our ambitions extend far beyond hair analysis.
Another core pillar of our business is the end‑to‑end design of biomarker discovery, assay development, and clinical application. At the center of this effort is our fully automated ELISA platform, KI‑ZA‑SHI.
KI‑ZA‑SHI is an automated measurement platform developed to enhance reproducibility, efficiency, and analytical precision in research environments. It supports next‑generation neurological biomarkers such as p‑tau217 and various amyloid‑β species, and is designed with a clear pathway from research use to future clinical application. In addition, by providing ELISA kits that support pre‑instrument research phases, we offer a seamless pathway from basic research to real‑world implementation.
We are not merely a company that sells products.
We aspire to be a company that captures the earliest signs of change—“kizashi”—and transforms them into the future of medicine. Our vision is to deliver value across the entire medical continuum—health, pre‑symptomatic states, onset, and prognosis. By connecting prevention, diagnostic support, research enablement, and drug discovery infrastructure, we aim to contribute to improving Life Time Value (LTV) in healthcare.
Our goal is not economic growth alone.
We are committed to addressing fundamental societal issues—environment, education, local communities, and welfare—and contributing to the creation of a sustainable future. Our mission is to transform scientific and technological advances into sources of hope for society.
“What is the value that is truly needed?”
With this question at our core, we will continue to take on new challenges. We believe that small, steady steps will eventually lead to major shifts that redefine the norms of medicine. Guided by this belief, we will continue contributing to society through both research and business.
SEKIGUCHI Takashi
Representative Director & President
YAC BIO INC.
